AUA Symptom Score

Related by string. * AuA . Auas : AUA pursues . AUA BPH Symptom Score . #bn AUA . AUA Annual Meeting . TSX AUA PINK / SYMPTOMS . Symptoms . SYMPTOM . symp toms . symptoms : urinary tract symptoms . respiratory symptoms . allergy symptoms . neurological symptoms / scor ed . SCORES . www.score . Scores : TIME SCORE MAR VISITORS . SCORE Trophy Truck . SCORE Desert Series . Industry Risk Score * *

Related by context. Frequent words. (Click for all words.) 63 achieved statistical significance 62 CI -#.# 62 placebo p 62 ADAS cog 60 statistically significant p = 60 ACR# response 60 sensitivity specificity 59 ADHD RS 59 serum phosphorus 59 Cmax 59 IPSS 59 placebo p = 59 Secondary endpoints included 58 prespecified 58 μg kg 58 mg kg dose 58 HbA 1c 58 statistically significant p 57 Secondary endpoints include 57 Secondary endpoints 56 preoperatively 56 virologic response 56 glycated hemoglobin 56 PANSS 56 tolvaptan 56 peginterferon alfa 2a 56 mg QD 56 ± SD 56 HbA1C 56 log# 56 P = .# 56 pg mL 56 noninferiority 56 elagolix 55 glycosylated hemoglobin 55 mcg kg 55 hemoglobin A1C 55 #mg dose [003] 55 LVEF 55 confidence interval #.#-#.# 55 symptom severity 55 plus methotrexate 55 sd = 55 mg BID 55 creatinine clearance 54 Pharmacokinetic 54 ANOVA 54 QTc 54 virologic 54 Negative Syndrome 54 tocilizumab 54 irbesartan 54 ± 54 WOMAC 54 CI #.#-#.# [002] 54 glomerular filtration rate 53 HbA1c levels 53 tiotropium 53 plus dexamethasone 53 plus prednisone 53 EBRT 53 active comparator 53 univariate analysis 53 estimated glomerular filtration 53 postoperatively 53 glimepiride 53 low dose dexamethasone 53 unfractionated heparin 53 demonstrated statistically significant 53 logistic regression 53 DOXIL 52 systemic embolism 52 median PFS 52 primary efficacy endpoint 52 abciximab 52 rotigotine 52 mg doses 52 tamsulosin 52 chemoradiotherapy 52 bosentan 52 pg ml 52 mycophenolate mofetil 52 FOLFIRI 52 peginterferon alfa 2b 52 carotid intima media 52 echocardiographic 52 serum uric acid 52 azacitidine 52 sustained virologic response 52 Main Outcome Measures 52 decitabine 52 DAS# [002] 52 HRQOL 52 mg dose 52 #mg/kg [002] 52 cytogenetic response 52 D dimer 52 p = #.# [002] 51 annualized relapse 51 clinically meaningful 51 adalimumab

Back to home page